MedPAC > Our Work > Drugs, Devices, and Tests > MedPAC comment on CMS’s advance notice of methodological changes for CY 2026 for Medicare Advantage capitation rates and Part C and D payment policies
MedPAC comment on CMS’s advance notice of methodological changes for CY 2026 for Medicare Advantage capitation rates and Part C and D payment policies